Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To study the effects of GLP 1 analogues and DPP 4 inhibitors on newly detected type 1 diabetes patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Command Hospital, India
• Treatments: Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Insulin; Insulin, Globin Zinc; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• T1DM <3 months

• GAD Antibody+ or Stimulated C peptide<0.5 ng/ml

• Ketosis at onset

• Age < 30 yr

Exclusion Criteria:

• Age > 30 yr

• Pancreas disease

• Significant systemic disease